MARKET

CRVO

CRVO

CervoMed
NASDAQ
14.52
+2.96
+25.56%
Opening 15:00 03/21 EDT
OPEN
12.09
PREV CLOSE
11.56
HIGH
16.94
LOW
12.09
VOLUME
6.74M
TURNOVER
--
52 WEEK HIGH
26.38
52 WEEK LOW
1.800
MARKET CAP
126.32M
P/E (TTM)
-7.1931
1D
5D
1M
3M
1Y
5Y
1D
CervoMed Inc trading resumes
TipRanks · 6h ago
CervoMed Inc trading halted, volatility trading pause
TipRanks · 6h ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 1d ago
CervoMed Is Maintained at Buy by Roth MKM
Dow Jones · 3d ago
Roth MKM Maintains Buy on CervoMed, Raises Price Target to $20
Benzinga · 3d ago
CervoMed Is Maintained at Buy by Canaccord Genuity
Dow Jones · 3d ago
CervoMed Price Target Raised to $21.00/Share From $12.00 by Canaccord Genuity
Dow Jones · 3d ago
Canaccord Genuity Maintains Buy on CervoMed, Raises Price Target to $21
Benzinga · 3d ago
More
About CRVO
CervoMed Inc. is a clinical-stage biotechnology company focused on developing treatments for age-related neurologic disorders. It is focused on the development of its lead drug candidate, neflamapimod, an investigational, orally administered, small molecule brain penetrant that inhibits p38a in the neurons (nerve cells) within the brains of people with neurodegenerative diseases. Its neflamapimod is in clinical development as a disease-modifying treatment for neurodegenerative diseases, such as dementia with Lewy Bodies and early Alzheimer’s disease. In addition, pre-clinical data supports the potential role of neflamapimod in recovery after stroke. Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in dementia with Lewy bodies (DLB) and certain other neurological disorders. It is being evaluated in its ongoing RewinD-LB Trial, a Phase 2b study in patients with DLB.

Webull offers CervoMed Inc stock information, including NASDAQ: CRVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRVO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRVO stock methods without spending real money on the virtual paper trading platform.